Drug Trial Radar · NCT03575104
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Last checked: Nov 19, 2026Latest source record: Mar 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
924
Actual
Start
May 29, 2018
Primary completion
Apr 9, 2020
Study completion May 14, 2020
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 2, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Conditions
- Insomnia Disorder
Interventions
DaridorexantDrug
Daridorexant will be administered as tablets, orally, once daily in the evening.
PlaceboOther
Matching placebo will be administered as tablets, orally, once daily in the evening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Month 1 in Wake After Sleep Onset (WASO) (Sleep Maintenance)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
- Change From Baseline to Month 3 in Wake After Sleep Onset (WASO)Time frame: From baseline to Month 3 (i.e. for up to 3 months)
- Change From Baseline to Month 1 in Latency to Persistent Sleep (LPS) (Sleep Onset)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
- Change From Baseline to Month 3 in Latency to Persistent Sleep (LPS)Time frame: From baseline to Month 3 (i.e. for up to 3 months)
Locations
86 sites in 11 countries. Site status is shown where the registry gives one.
Pulmonary Associates, Pa
Glendale, Arizona
Noble Clinical Research
Tucson, Arizona
Baptist Health Center for Clinical Research
Little Rock, Arkansas
Woodland International Research Group
Little Rock, Arkansas
Core Healthcare Group
Cerritos, California
Artemis Institute For Clinical Research - Riverside
Riverside, California
Pacific Research Network
San Diego, California
Artemis Institute for Clinical Research
San Marcos, California
Santa Monica Clinical Trials
Santa Monica, California
Empire Clinical Research
Upland, California
Innovative Clinical Research
Lafayette, Colorado
Clinical Research of South Florida
Coral Gables, Florida
Fleming Island Center for Clinical Research
Fleming Island, Florida
Clinical Trials Research
Lincoln, Florida
Clinical Research Group of St. Petersburgh
St. Petersburg, Florida
Neurotrials Research Incorporated
Atlanta, Georgia
Sleep Practitioners, LLC
Macon, Georgia
Hawaii Pacific Neurosciences
Honolulu, Hawaii
Saltzer Clinical Research
Nampa, Idaho
Rowe Neurology Institute
Lenexa, Kansas
Sleep Disorders Center of the Mid-Atlantic
Glen Burnie, Maryland
Neurocare Inc.
Newton, Massachusetts
Precise Research Centers
Flowood, Mississippi
Garden City Asthma and Sleep Center
Garden City, New York
Research Carolina of Hickory
Hickory, North Carolina
Wake Research Associates
Raleigh, North Carolina
Clinical Trials of America - NC, LLC
Winston-Salem, North Carolina
CTI Clinical Research II
Cincinnati, Ohio
Ohio Sleep Medicine Institue
Dublin, Ohio
Cleveland Sleep Research Center
Middleburg Heights, Ohio
Robert V. Sibilia, MD, Inc.
Wooster, Ohio
Brian Abaluck LLC
Paoli, Pennsylvania
Wesley Neurology Clinic Pc (Multiple Sclerosis)
Cordova, Tennessee
FutureSearch Trials of Neurology, LP
Austin, Texas
InSite Clinical Research
DeSoto, Texas
Jacksonville Center for Clinical Research
Jacksonville, Texas
Dm Clinical Research / Martin Diagnostic Clinic
Tomball, Texas
HOSPITAL AZ SINT-JAN_Neurology department
Bruges, Belgium
Hospital Universitair Zieknhuis Brussel, Pneumology and Sleep Laboratory
Brussels, Belgium
University Hospital Gent, Department of General Internal Medicine and Center of neurophysiological Monitoring
Ghent, Belgium
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.